title: Immune profiling players shift gear to guide cancer drug development.
authors.forename: Michael
authors.initials: M
authors.lastname: Eisenstein
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015195:Drug Design; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents